🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/10/1978 | 1,46 | 1,54 | 1,42 | 1,54 | +5,91% | 8,18% | 1.920.355 |
| 27/10/1978 | 1,48 | 1,48 | 1,46 | 1,46 | -1,35% | 1,79% | 1.494.029 |
| 26/10/1978 | 1,49 | 1,49 | 1,46 | 1,48 | -1,33% | 2,00% | 2.025.994 |
| 25/10/1978 | 1,51 | 1,52 | 1,48 | 1,50 | -1,09% | 2,62% | 1.580.803 |
| 24/10/1978 | 1,52 | 1,53 | 1,51 | 1,51 | -0,66% | 1,31% | 1.090.339 |
| 23/10/1978 | 1,50 | 1,53 | 1,50 | 1,52 | +1,77% | 1,99% | 1.799.626 |
| 20/10/1978 | 1,51 | 1,53 | 1,50 | 1,50 | -1,09% | 1,97% | 1.603.440 |
| 19/10/1978 | 1,51 | 1,53 | 1,51 | 1,51 | +0,22% | 1,10% | 1.343.117 |
| 18/10/1978 | 1,52 | 1,53 | 1,51 | 1,51 | -0,43% | 1,53% | 1.003.565 |
| 17/10/1978 | 1,54 | 1,54 | 1,50 | 1,52 | -1,93% | 2,58% | 2.444.774 |
| 16/10/1978 | 1,58 | 1,58 | 1,55 | 1,55 | -1,89% | 1,89% | 1.452.528 |
| 13/10/1978 | 1,58 | 1,59 | 1,58 | 1,58 | +0,00% | 0,84% | 1.471.392 |
| 12/10/1978 | 1,60 | 1,60 | 1,58 | 1,58 | -1,65% | 1,45% | 2.305.181 |
| 11/10/1978 | 1,58 | 1,61 | 1,58 | 1,60 | +1,26% | 1,67% | 2.263.680 |
| 10/10/1978 | 1,59 | 1,60 | 1,57 | 1,58 | -0,42% | 1,46% | 1.712.851 |
| 09/10/1978 | 1,55 | 1,60 | 1,55 | 1,59 | +3,01% | 2,77% | 1.516.666 |
| 06/10/1978 | 1,55 | 1,57 | 1,54 | 1,54 | -0,43% | 1,72% | 1.124.294 |
| 05/10/1978 | 1,58 | 1,58 | 1,55 | 1,55 | -1,68% | 1,68% | 1.844.899 |
| 04/10/1978 | 1,58 | 1,59 | 1,55 | 1,58 | -0,21% | 2,09% | 1.505.347 |
| 03/10/1978 | 1,60 | 1,60 | 1,58 | 1,58 | -1,04% | 1,04% | 1.569.485 |
| 02/10/1978 | 1,59 | 1,63 | 1,58 | 1,60 | +0,42% | 2,92% | 3.176.698 |
| 29/09/1978 | 1,58 | 1,59 | 1,58 | 1,59 | +0,84% | 0,84% | 2.059.949 |
| 28/09/1978 | 1,56 | 1,58 | 1,55 | 1,58 | +1,28% | 1,70% | 1.312.934 |
| 27/09/1978 | 1,58 | 1,60 | 1,55 | 1,56 | -1,67% | 2,93% | 1.867.536 |
| 26/09/1978 | 1,59 | 1,59 | 1,58 | 1,58 | -0,42% | 0,83% | 1.629.850 |
| 25/09/1978 | 1,60 | 1,60 | 1,57 | 1,59 | -1,03% | 1,86% | 1.245.024 |
| 22/09/1978 | 1,61 | 1,63 | 1,60 | 1,61 | -0,20% | 2,06% | 2.410.819 |
| 21/09/1978 | 1,63 | 1,63 | 1,60 | 1,61 | -1,22% | 2,23% | 3.644.525 |
| 20/09/1978 | 1,65 | 1,66 | 1,62 | 1,63 | -1,21% | 2,21% | 1.626.077 |
| 19/09/1978 | 1,64 | 1,67 | 1,64 | 1,65 | +0,81% | 1,82% | 1.512.893 |